Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice. (Record no. 16038813)

MARC details
000 -LEADER
fixed length control field 01660 a2200493 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515013146.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200605s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0269-2813
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/j.1365-2036.2006.02748.x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Lee, S S
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20060504
245 00 - TITLE STATEMENT
Title Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Alimentary pharmacology & therapeutics
Date of publication, distribution, etc. Feb 2006
300 ## - PHYSICAL DESCRIPTION
Extent 397-408 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Canada
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis C, Chronic
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon alpha-2
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon-alpha
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Polyethylene Glycols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recombinant Proteins
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ribavirin
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bain, V G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Peltekian, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Krajden, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yoshida, E M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Deschenes, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Heathcote, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bailey, R J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Simonyi, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sherman, M
773 0# - HOST ITEM ENTRY
Title Alimentary pharmacology & therapeutics
Related parts vol. 23
-- no. 3
-- p. 397-408
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/j.1365-2036.2006.02748.x">https://doi.org/10.1111/j.1365-2036.2006.02748.x</a>
Public note Available from publisher's website

No items available.